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ANALISA IMMUNOPROTEOMIK Mycobacterium tuberculosis DAN 
MIKOBAKTERIA BUKAN TUBERKULOSIS KE ARAH PENEMUAN BIO-
PENANDA YANG BERPOTENSI UNIVERSAL ATAU SPESIFIK KEPADA 
SPESIS 
  
ABSTRAK 
 
Analisa immunoproteomik keseluruhan sel protein (WCP) Mycobacterium 
tuberculosis dan mikobacteria bukan tuberculosis (NTM) telah dijalankan bagi 
mengenalpasti kehadiran bio-penanda yang berpotensi spesifik kepada spesis atau 
universal yang wujud di dalam mikobacteria. WCP daripada beberapa spesis 
mikobacteria telah dipisahkan menggunakan SDS-PAGE dan diikuti dengan WB bagi 
mengesan tindak balas imun antibodi isotip IgM, IgG dan IgA di dalam serum 
kumpulan pesakit tuberculosis (TB), kumpulan subjek yang sihat dan serum setiap 
individu tersebut. Reaksi WB dapat dibahagikan kepada 4 bahagian; bahagian (1) atas 
67 kDa ; (2) 67 kDa – 32 kDa ; (3) 30 kDa, 28kDa dan 26 kDa; dan (4) bawah 25 kDa. 
Berdasarkan keputusan WB, dua spesis telah dipilih iaitu M. tuberculosis H37Rv dan 
M. abscessus untuk kajian selanjutnya. Kedua-dua spesis tersebut telah ditulenkan dan 
dipecahkan menggunakan sistem persediaan Rotofor IEF dan dicirikan dengan kaedah 
analitikal poliakrilamida gel IEF (PAGE IEF) diikuti dengan kaedah blot imun. 
Berdasarkan keputusan blot imun, 2 pecahan daripada setiap spesis; pecahan F1 dan 
F16 M. tuberculosis H37Rv dan pecahan F1 dan F3 M. abscessus dipilih untuk 
pencirian bagi mengenalpasti protein-protein dengan kaedah Spektrometri Jisim 
Matrix-Assisted Laser Desoption-Ionization Time of Flight (MALDI-TOF MS).  
Dengan menggunakan kaedah tersebut, sebanyak 4 jalur dipotong daripada gel 
 xix 
 
persediaan PAGE-IEF pecahan  M. tuberculosis H37Rv (dikodkan sebagai : T1B1, 
T1B2, T16B1 and T16B2) dan sebanyak 7 jalur bagi pecahan M. abscessus (dikodkan 
sebagai : A1B1, A1B2, A2B3, A3B1, A3B2, A3B3 and A3B4). Kaedah MALDI-TOF 
mengarahkan kepada identifikasi 21 peptida M. tuberculosis H37Rv dan 8 peptida M. 
abscessus. Setiap satu peptida daripada M. tuberculosis H37Rv mengarahkan kepada 
identifikasi protein yang berbeza dengan pelbagai kategori fungsi. Selain daripada itu, 
3 peptida M. abscessus mendedahkan kepada identifikasi protein yang sama walaupun 
daripada jalur yang berbeza di dalam pecahan F3. Keputusan dari kajian ini juga 
menunjukkan protein reaktif imun yang dikenalpasti tidak pernah dilaporkan sebagai 
antigen di dalam mana-mana kajian sebelum ini, walaupun antigenisiti protein ini telah 
dapat dilihat dan disahkan di dalam blot imun PAGE IEF. Oleh itu, analisa selanjutnya 
diperlukan kerana protein-protein yang dikenalpasti ini mempunyai potensi sebagai 
bio-penanda untuk diagnosis TB dan juga bagi penghasilan vaksin yang lebih baik 
untuk TB.  
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IMMUNOPROTEOMIC ANALYSIS OF Mycobacterium tuberculosis AND 
NONTUBERCULOUS MYCOBACTERIA TOWARDS THE DISCOVERY OF 
POTENTIAL UNIVERSAL OR SPECIES SPECIFIC BIOMARKERS 
 
  ABSTRACT 
 
The immunoproteomic analysis of whole cell protein (WCP) of Mycobacterium 
tuberculosis complex (MTBC) and non–tuberculous mycobacteria (NTM) was carried 
out to identify the potential species specific and cross genus conserved species 
biomarkers present in the mycobacterial species. The WCP of Mycobacterium species 
were separated using SDS-PAGE and followed by Western blot assay to detect IgM, 
IgG and IgA immune response in pooled sera of TB patients and healthy subjects as 
well as the individual sera. The immunoreactive bands in WB assay were divided into 
4 region of antigens; (1) above 67 kDa; (2) 67 kDa – 32 kDa; (3) 30 kDa, 28kDa and 
26 kDa; and (4) below 25 kDa. Based on the WB results, the two species selected for 
further investigation were M. tuberculosis H37Rv and M. abscessus. The WCP of 
these species were purified and fractionated by preparative rotofor isoelectric focusing 
(IEF) system and characterized by analytical polyacrylamide gel (PAGE IEF) followed 
by immunoblotting. Based on the immunoblotting results, 2 fractions from each 
species were selected. These include fraction F1 and F16 of M. tuberculosis H37Rv 
and fraction F1 and F3 of M. abscessus. The proteins from the selected fractions were 
subjected to identification by MALDI-TOF MS. Employing the approach, a total of 4 
bands were excised from preparative PAGE-IEF gel of M. tuberculosis H37Rv’s 
fractions (encoded as: T1B1, T1B2, T16B1 and T16B2) and a total of 7 bands from 
M. abscessus’s fractions (encoded as: A1B1, A1B2, A2B3, A3B1, A3B2, A3B3 and 
 xxi 
 
A3B4). The MALDI-TOF led to the identification of 21 peptides from M. tuberculosis 
H37Rv and 8 peptides from M. abscessus. Each single peptides from M. tuberculosis 
H37Rv led to the identification of different proteins with various functional category. 
On the other hand, 3 peptides from M. abscessus revealed the identification of the same 
protein as the peptides from the bands in the particular fractions were fragmented 
during MALDI-TOF. The results from this study also showed the identified 
immunoreactive proteins has yet to be reported in other previous studies but the 
antigenicity of these proteins were observed and confirmed in this study. Thus, further 
analysis need to be done as the identified proteins from this study hold the potential as 
biomarkers for TB diagnosis and also for improved vaccine development for TB. 
 
 
 
  
 
1 
 
 Chapter 1  
 
General Introduction 
 
1.1 Historical perspectives of mycobacterial diseases 
 
Major mycobacterial diseases in human are tuberculosis (TB) and leprosy. Leprosy is 
a localized infectious disease confined to skin and caused by Mycobacterium leprae 
(Portaels, 1995; Steingart et al., 2007). On the other hand, TB is a systemic infectious 
disease of multi organ systems. However, pulmonary TB is most frequently 
implicated. The description of Mycobacterium tuberculosis started in 1826 followed 
by its discovery in 1882 by Robert Koch. Another early discovery of mycobacterial 
disease, leprosy was discovered by Hensen in 1873 (Schuster, 1995; Sato and Frantz, 
2005). The identification of non-tuberculous mycobacteria (NTM) started shortly after 
that but often abandoned during the period. However, it manage to draw attention due 
to the increasing reports of infections caused by NTM (Portaels, 1995; Schuster, 1995; 
Moore et al, 2010; Mirsaeidi et al., 2014). 
 
1.2 Epidemiology of tuberculosis 
  
TB remain as one of the second leading cause of death in developing countries together 
with malaria and AIDS. The World Health Organization (WHO) declared TB as a 
global health emergency in 1993 due to the dramatic changes in the magnitude of the 
problem (Wangdi and Gurung, 2012; Ejeta et al., 2013). It was also reported by WHO 
in 2009 there were almost 13.7 million people infected with TB and compared to other 
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infectious disease, TB kills more young people and adults (Jassal and Bishai, 2010). 
In addition, it was estimated that out of 2 billion individuals infected with TB, only 
10% develop active TB while the remaining 90% individuals may develop latent TB 
(Demissie et al., 2006). The resurgence and increasing number of cases of TB may 
have related to several factors including the emergence of multi- drug resistant TB 
(MDR-TB), HIV epidemic, failure to comply to antibiotic treatment, ineffective 
control programs, population growth and as well the migration of people from 
countries with high prevalence of TB (Coker, 2004; Nissapatorn et al, 2007; Alavi and 
Alavi, 2013). 
 
Raviglione and team (1995) stated that global notifications rate per 100 000 
populations were increased in the WHO regions such as African, the East 
Mediterranean, the Southeast Asian and the Western Pacific (Raviglione et al., 1995). 
By comparing the data obtained between 1984 to 1986 and 1989 to 1991 has shown 
notifications rate increment of 20.8% compared to the latter (Werf and Antoine, 2015). 
In addition, this trend was also followed by the developing countries worldwide. 
However, the regions such as American and European showed the decreasing in 
average number of cases.  
 
In 2005, it has been reported that Asia; Bangladesh, China, India, Indonesia and 
Pakistan contributed to 49% of new TB cases worldwide (Kaufmann and Helden, 
2008).  This was supported by the recent report by Glaziou et al., (2015) that higher 
proportions of estimated cases in 2012 which majority of the cases come from 
Southeast Asia and 27% from Africa.  
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In Africa, HIV had the greatest impact on the mortality of TB (Glazio et al., 2013). 
According to Dye (2006), the African region was reported to have the highest 
estimation of incidence rate which is 356 per 100 000 population per year. Improper 
management of TB control as well as the disruption of political, social and economical 
explained the resurgence of TB in 1990s (Dye, 2006; Glazio et al.,  2013). 
 
1.3 Epidemiology of tuberculosis in Malaysia 
 
Historically back in 1940s and 1950s, TB was the leading cause of death due to 
infectious disease in Malaysia (Iyawoo, 2004). Since 1950s the enormous effort and 
strategy have been done in order to eradicate the disease. The chemotherapy only 
available in late 1950s when TB has become the major cause of morbidity and 
mortility (Iyawoo, 2004). In addition, National Control TB Program (NTP) was 
launched in 1961 and play as an important role for TB management and control. The 
efforts gave a successful outcome as the disease significantly declined and it was 
believed in 1980s, TB was no more a major threat in Malaysia (Shanmuganathan and 
Subramaniam, 2013). However, the notifications rate per year keeps increasing in 
these past 20 years. Among all of the notified TB cases in Malaysia, 10% are 
contributed by the influx of immigrant population from the neighbouring countries 
especially Indonesia, Myanmar, Bangladesh and India (Iyawoo, 2004; 
Shanmuganathan and Subramaniam, 2013). In addition, according to the data in 
Tuberculosis Information System (TBIS), Ministry of Health, the incidence rate of  
active TB among health care personnel was higher than general population from 2003 
t0 2006 which is 73.4 - 77.7 per 100,000 and 60.3-62.6 per 100,000 respectively 
(Rafiza et al.,2011).  The state of Sabah was reported with highest burden of TB with 
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the estimated incidence rate 131 per 100, 000 populations and this followed by Federal 
Territory, state of Sarawak and state of Penang (Iyawoo, 2004; Ali et al., 2015). 
 
1.4 The genus of Mycobacterium 
 
1.4.1 Classification 
 
The identification and description of tubercle bacilli by Robert Koch began in the late 
1800s. In 1896, Lehmann and Neumann identified Mycobacteria and proposed the 
genus Mycobacterium and renamed the tubercle bacilli as Mycobacteria tuberculosis 
(Collins et al., 1982; Shinnick and Good, 1994). The genus was placed in family of 
Mycobacteriaceae, order of Actinomyceteles and class of Actinomycetes (Shinnick and 
Good, 1994). Taxonomically, mycobacteria belong to the genus Mycobacterium 
which one of the oldest defined genus and single genus within the family of 
Mycobacteriaceae (Rastogi et al., 2001; Saviola and Bishai, 2006). The genus 
currently comprises of 163 mycobacteria species and 13 subspecies which includes 
the complex group of M. tuberculosis (MTBC) and environmental mycobacteria group 
according to list of bacteria species names with approved names 
(www.bacterio.cict.fr/m/mycobacterium.html) (Zivanovic et al., 2014).  
 
In addition, due to the similar characteristics with Nocardia and Corynebacterium, 
additional criteria were developed to differentiated these groups which includes Gram 
staining, growth rate, penicillin resistance, percentage of guanine-cytosine (GC) 
content, mycolic acid profiles and arylsulfatase production (Shinnick and Good, 
1994). Hartmans and others reported, the differentiation of these three genera by 
  
 
5 
 
mycolic acid content can be done through chemical differentiation ester pyrolysis 
product of the mycolic acid esters, in combination with the identification of the major 
menaquinone present in the plasma membrane (Hartmans et al.,2006). The unique 
characteristic of the species in the genus is their ability to synthesis mycolic acids with 
additional oxygenated functions such as methoxy, keto, epoxy and carboxylic. In 
Mycobacterium, the species usually contains 60-90 carbon atoms which are cleaved 
at C22 to C26 fatty acid methyl by pyrolysis (Shinnick and Good, 1994). On the other 
hand, species of Norcardia and Corynebacterium contains 44-60 and 22-36 carbon 
atoms which cleaved at C14 to C18 and C8 to C18 fatty acid methyl, respectively 
(Hartmans et al.,2006). The presence of this oxygenated mycolates has made it as the 
criteria for including an organism in the genus Mycobacterium (Frebault and Portaels, 
1992).  
 
Following Robert Koch discovery, the other type of tubercle bacilli were discovered 
such as bovine types, avian type and marine type. Within the genus Mycobacterium 
itself, there are number of complex group were formed eg: M. tuberculosis complex 
(MTBC) and M. avium complex (MAC) (Saviola and Bishai, 2006). The species were 
assigned in particular group based on their genetically high degree of similarities and 
the formation of similar syndrome of the disease. In MTBC group, it comprised of 
closely related Mycobacterium species such as M. tuberculosis, M. bovis, M. bovis 
BCG, M. africanum, M. microti and M. canetti which are the etiologic agents for 
tuberculosis in mammals and human (Medie et al., 2011). Taxonomically, despite 
sharing >95% of DNA-DNA homology with one another among the species in 
complex group, the members of MTBC differ in their host range and pathogenicity 
(Shinnick and Good, 1994; Niemann et al., 2000). For example, M. tuberculosis and 
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M. bovis can be distinguish through the biochemical test in clinical laboratory (Good, 
1985).  
 
The atypical mycobacteria previously referred as environmental mycobacteria, 
mycobacteria other than tubercle (MOTT) or opportunistic mycobacteria, though the 
term non-tuberculous mycobacteria (NTM) is preferred (Koh et al., 2002). After the 
discovery of this group of mycobacteria, several numbers NTM were found to cause 
disease in humans (Hartmans et al., 2006). Thus, the identification and classification 
are necessary. 
 
The first classification of NTM was proposed by Timpe and Runyon in 1954 based on 
the growth rates, colony morphology and chromogenicity (Koh et al., 2002; Marusic 
and Jankovic, 2012). In the first classification, Runyon proposed a classification of 
NTM into 4 major groups. The four groups consists of photochromogens, 
schrotochromogens, non-chromogens and rapid grower group (eg: M. fortuitum) 
(Goods, 1985). The first 3 groups are considered slow growers which requiring a time 
to grow in culture as M. tuberculosis (Rastogi et al., 2001). The slow grower species 
are further differentiated according to their ability to produce yellow pigment (Koh et 
al., 2002). The growing duration of slow grower mycobacteria usually takes 15-30 
days while rapid grower mycobacteria takes 2-7 days to grow on the culture medium 
before the sufficient growth is achieved (Shinnick and Good, 1994; Saviola and 
Bishai, 2006). 
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1.4.2 Bacteriology of Mycobacteria 
 
Mycobacteria are non-motile rod shaped bacterium with <5µm in length, acid-alcohol 
fast, aerobic and composed of complex cell envelope. The cell envelope consists of a 
plasma membrane, a peptidoglycan layer, a hydrophobic thick mycolate layer and 
outer lipids (Brennan and Nikaido, 1995; Barry et al. 1998; Osoba, 2004; Marrakchi 
et al., 2014). Mycobacteria are not classified either Gram positive or Gram negative 
due to the high lipid content on the cell wall which resist decolorization of acid-
alcohol. Hence, known as acid-fast bacteria (Leung, 1999).  
 
Mycobacterium species have been isolated from diverse habitats of origin including 
mammalian and non-mammalian habitat. For instance, soil, fresh, salt water, drinking 
water system and dust usually imply to the NTM species. Most of the NTM species 
are environmental organism which are not associated with infections and disease 
(Wang and Behr, 2014). However, the pattern changed since 1980 when the outbreak 
of AIDS starting in 1982 and infections of M. avium were reported in AIDS patients 
(Narang 2008; Falkinham, 2009). The fact that NTM species sharing habitats with 
human and animals is clearly major determinant in disease acquisition (Falkinham, 
2009). Unlike NTM, M. tuberculosis is an obligate pathogen of human which adapted 
well in the host and no known environmental reservoir (Wang and Behr, 2014). M. 
tuberculosis have the ability to survive and replicate in human macrophages. Thus, 
make the macrophages as its major habitat inside the host (Danelishvili et al., 2014).  
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Mycobacterium species are usually subculture on the egg-based medium eg: 
Lowenstein Jensen (conventional standard media) or Middlebrook media. The 
bacterium grow at 37°C and produce typical small, rough or smooth and buff colour 
colony morphology on the culture media usually after 2-4 weeks of incubation. On the 
other hand, as aforementioned in Runyon classification, NTM species can be 
distinguished based on the production of colour pigment and growth rate (Johnson and 
Odell, 2014). Among the rapid grower species of NTM, they usually form bright 
yellow or orange coloured colonies subjected to carotenoid pigments and familiarity 
with Runyon classification remains useful for presumptive laboratory identification of 
possible NTM pathogens. However, positive identification of NTM species are largely 
based on the biochemical test and other molecular techniques (Ioachimescu and 
Tomford, 2010).  
 
1.5 Mode of transmission 
 
TB is an airborne disease and mode of transmission is from human-to-human via air 
droplet. Since the habitat of MTBC species are in the host of human and animal, 
transmission occurs through the inhalation of the air droplet nuclei containing the 
bacilli  which are typically expelled and suspended in the air when a patient with active 
TB coughing or sneezing. The primary route of infection involves the lungs due to the 
small size. The bacilli can remain suspended in the air for several minutes to hours. 
Thus, the bacteria can be transmitted from one person to another and the risk of getting 
infected is high for the individuals with close contact to the patient with active TB 
(Ahmad, 2011; Shakri et al., 2012).  
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In addition, the risks of infection depend on several factors such as closeness of 
contact, inhaled bacillary load and the immune status of the potential host. There are 
also several reported cases of tuberculosis in animal species which lived close and 
prolonged contact with humans. The infection of M. tuberculosis in the animal usually 
identified in cattle (Ocepek et al., 2005; Romero et al., 2011).  
 
1.6 Clinical manifestations 
 
1.6.1  Tuberculosis 
 
The stages of TB may develop differently for each patient according to their status of 
immune system. The stages of progress of the disease include latency, primary disease, 
primary progression of the disease and extrapulmonary disease (Knechel, 2009). At 
the stage of latency, infected individuals are asymptomatic. The viable bacilli may 
remain dormant and survive for years or decades. As the immune system of the person 
start to weaken, the disease may start to reactivate. An individual that has co-infection 
with human immunodeficiency virus (HIV) may show the prominent progression 
towards active disease stage. Besides that, other factors such as old age, malnutrition, 
uncontrolled diabetes mellitus, sepsis, renal failure, smoking, chemotherapy and organ 
transplantation that lead to diminishing in immunity may trigger the reactivation of 
the bacilli towards the active stage of the disease (Knechel, 2009).  
 
At the stage of primary disease, the person may not show any symptoms and the 
diagnostic tests are the only evidence in order to confirm the disease. At this point, the 
bacilli that has been implanted in the alveoli will spread from the lungs through the 
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lymphatic circulation which later on may cause pleural effusion (Smith, 2003; 
Knechel, 2009). It may remain small and in some cases, it may resolve by itself or it 
also may become large to induce symptoms fever, pleuritic chest pain and dyspnea 
(Smith, 2003; Knechel, 2009).  
 
The next stage of the disease is a primary progressive disease or active disease which 
develops in only 5 % to 10% of persons that exposed to M. tuberculosis. At this stage, 
the patients may start showing non-specific symptoms such as fatigue, malaise, weight 
loss, fever and night sweats. Wasting has been recognized as the classical feature of 
TB due to the reduction in appetite and lead to a decreased in energy intake. Wasting 
also usually comprises loss of fats and lean tissue. Thus, decreased muscle mass may 
contribute to the fatigue (Paton et al., 2004). Coughing is a common symptom of the 
disease even though initially it is non-productive, later on it may advance to a 
productive cough with purulent sputum. In addition, pleurisy or inflammation of the 
pleural surface may occur due to rupture of a subpleural space caseous focus in the 
lung into the pleural space resulted from the hematogeneous dissemination or the 
release of bacteria from subpleural of caseous focus in the lungs (Ferrer, 1997; Smith, 
2003; Jeon, 2014). 
 
Knechel reported extrapulmonary disease occurs in more than 20% of 
immunocompetent individual and the risk in getting extrapulmonary disease increase 
with immunosuppression (Knechel, 2009).  Extrapulmonary TB, involving multi 
organ system usually arise from the dissemination of the bacilli from lung which is 
the primary site of infection. High percentage of extrapulmonary TB was reported in 
the USA (1964-1989) compared to the developing countries (Smith, 2003). Besides 
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that, cases reported in the literature showed that organ systems associated with 
extrapulmonary TB are varies in a mixed population within a country. In the related 
study in England showed 20% of the TB patients originated from Europe had 
extrapulmonary TB which involved lymph node, bone and joints while 90% are 
associated with genitourinary. On the other hand, 60% out of 45% extrapulmonary TB 
in patients originated from India subcontinent showed association with lymph node, 
bones and joints (Yates and Grange, 1993).  
 
Miliary TB is another form of the extrapulmonary TB that is due to septicemia. The 
dissemination of the bacilli will involves other multiorgan. Miliary TB can be difficult 
to diagnose due to the nonspecific signs such as fever, weight loss and weakness 
(Knechel, 2009). Another fatal form of extrapulmonary TB is where the infection takes 
place in the central nervous system and it may result in meningitidis. Tubercular 
meningitidis is fatal in most cases if it is not treated. Headaches and mental confusion 
are the common manifestation of the disease. Another part of the body that may 
involve in the case of extrapulmonary TB includes bones, joints, pleura and 
genitourinary system.  
 
1.6.2 NTM infections 
 
NTM species are frequently isolated from environment and often harmless to human. 
However, they also may responsible in causing opportunistic disease in the subjects 
presenting with various predisposing condition (Tortoli, 2009). The four distinct 
clinical syndromes of NTM infections are progressive pulmonary disease, superficial 
lymphadenitis, disseminated disease and skin and soft tissue infection (Griffith, 2015).  
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The progressive pulmonary disease takes place in the lungs because it can easily be 
infected through inhalation of aerosolized mycobacteria. Among HIV-negative 
patients, the manifestation range from asymptomatic to cavitary disease while X-ray 
may reveal fibrosis, upper lobe cavitation, nodular or parenchymal opacity, and pleural 
thickening (Tortoli, 2009). The most affected population is elderly patients with 
predisposing pulmonary conditions such as obstructive pulmonary disease, 
bronchiectasis, pneumoconiosis or cancer. On the other hand, the radiographic image 
in AIDS patients are usually normal with rapid progression. The immunocompromised 
patients have low CD4 lymphocytes count. The use of anti-retroviral treatment has 
reduced the frequency of mycobacterial pulmonary disease in HIV-positive patients 
(Tortoli, 2009). The superficial lymphadenitis are common among the children which 
most of the cases affected cervical lymph nodes and caused by M. avium complex 
(MAC) and M. scrofulaceum (Griffith, 2015). On the other hand, disseminated disease 
develop mostly in severely immunocompromised patients. The two major routes of 
infection involve respiratory apparatus and gastrointestinal tract. Disseminated MAC 
was one of the first opportunistic infections detected in AIDS patients (Tortoli, 2009). 
For skin and soft tissue infection, it usually infect as the results of direct inoculation. 
The site of infections usually involve hand, elbow, knee and foot which the infections 
of cutis and soft tissue are characterized by granulomatous lesions developing a few 
weeks after infection (Tortoli, 2009). The source of infection include contact with 
contaminated water or infected fish, traumas and surgical wounds (Tortoli, 2009). 
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1.7 Pathogenesis 
 
1.7.1 Pathogenesis of tuberculosis 
 
The knowledge on the interaction between the host and bacteria is essential in 
understanding the pathogenesis of M. tuberculosis. As an intracellular pathogen, the 
tubercle bacilli is able to invade the host and successfully replicate within host 
macrophages (Smith, 2003). In addition, the bacteria also known to resist and evade 
the immune response of the host and able to modify the immune response of the host. 
The tubercle bacilli also able to persist within its host in dormant stage by developing 
granuloma (Smith, 2003). The virulence factors that contribute to the ability of the 
bacterium to survive in the host has been described based on their function and cellular 
localization such as secretory proteins, cell wall compartments, enzymes involved in 
lipid and fatty acid metabolism or in amino acid and purine biosynthesis, compounds 
required for metal uptake, oxidative stress proteins and transcription regulators 
(Mukhopadhyay et al., 2012).  
 
The acquisition of the infection start through the inhalation of air droplet contains 
tubercle bacilli and when the bacilli reach and when the bacilli arrived in the alveoli, 
it will start to interact with the alveolar macrophages through many different receptors 
(Rock et al., 2008). In contrast to other pathogenic bacteria, M. tuberculosis has no 
known as either endotoxins or exotoxins, therefore the host will not show any 
immediate immune response at the early stage of infection (Kabra et al., 2004; Sharma 
et al., 2005). M. tuberculosis is an intracellular pathogen, thus has the ability to survive 
over initial defenses, it will continue multiply within the alveolar macrophages. 
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Macrophages will ingest and contained the tubercle bacilli and continuous interaction 
between macrophages and the bacilli results in the formation of granuloma that keep 
the tubercle bacilli in a confine region in the lung. The tubercle bacilli in the granuloma 
are prevented from multiplication, stay dormant and develop into later stage of 
infection. At this stage, the majority of the infected individuals will remain “healthy” 
without showing any symptoms However, if the macrophages cannot destroy and 
inhibit the growth of M. tuberculosis, it may begin to multiply rapidly that will lead to 
the reactivation. 
 
Host pathogen interaction in TB is dominated by cellular immune response. The initial 
immune process will continue for 2- 12 weeks in which the bacteria will continue to 
grow until they achieved sufficient numbers to elicit cellular immune response. The 
immune response at this state commonly can be measured by Mantoux test (Diagnostic 
Standards and Classification of Tuberculosis in Adults and Children, 2000; Knechel, 
2009). Guidry et al. (2007) and Harding (2011) reported the persistency of the M. 
tuberculosis to survive in granuloma is contributed by the changes in bacterial 
metabolism as well as host metabolism which is part of the effector protein and 
glycolipids of M. tuberculosis (Guidry et al., 2007; Harding et al., 2011). The 
persistency of the bacilli is influenced by various conditions such as hypoxia, nutrient 
deficiency, acidic pH and inhibition of respiration by nitric oxide. In the state, the 
bacilli are able to control the growth, metabolic and replicative activity (Druszczynska 
et al., 2012).  
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1.7.2 Pathogenesis of NTM infections 
 
In contrast to M. tuberculosis, there is no evidence of person-to-person transmission 
of NTM as the diseases caused by NTM are not contagious. The NTM may take 
advantage and caused disease in individual due to altered local or systemic immunity 
such as patients with following trauma, lung disease history and immunosuppresion 
(Good, 1985; Katoch, 2004). In addition, their occurrence in the disease progress may 
suggests the source from where the organism derived (Good, 1985). The NTM 
infections by airborne pathway may contribute to respiratory disease. However, 
pulmonary disease which caused by NTM often mistakenly thought as tuberculosis 
due to the hardly distinguishable from clinical, radiological and historical aspects 
(Good, 1985).  
 
1.8 Differential diagnosis 
 
The most common disease that often confused with TB are pulmonary fibrosis, 
pneumonia, bronchiectasis, fungal disease, pleurisy, neoplasm, sarcoidosis, 
undetermined cause of granuloma and lung abscess (Bhatt et al., 2012). Chest 
radiography, positive tuberculin skin test result and detection of the acid-fast bacilli in 
the sputum remain as common method in diagnosis of TB. However, in any case which 
the result is lacking, consideration of differential diagnosis is necessary. For example, 
lung cancer, pulmonary amoebiasis and abscesses of unresolved pneumonia which 
caused by Klebsiella pneumoniae may appear as cavitary lesion on chest radiography. 
The absence of the acid-fast bacilli on microscopy may suggest to the above causes 
(Grange and Zumla, 2008). 
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1.9 Antimicrobial treatment and prognosis 
 
In treating TB, taking medication remains as the cornerstone in TB management but 
become complex with the emergence of multidrug-resistant TB (MDR-TB) and HIV 
coinfection with TB (Maher et al., 2003). Furthermore, the possibility of successful 
treatment of the disease are strongly depends on the completion of the prescribed 
treatment on TB patient. Interruption of the treatment will result on the progression 
and ongoing transmission of the disease and patients are at highly risk to develop 
MDR-TB (Maher et al., 2003).  
 
Upon discovery of streptomycin in 1943, it became the first effective anti-TB drug in 
treating TB (Lienhardt et al., 2012). Currently, the treatment for a confirmed case of 
active TB comprised of two phases; initial intensive phase and a continuous phase 
(Jain et al., 2008).  
 
During the intensive phase, a standard anti-TB therapy required 6 months duration of 
treatment. The first 2 month, patients will receive 3 to 4 drugs; rifampicin (R), 
isoniazid (H), pyrazinamide (Z) and in some cases ethambutol (E) will be given. In 
the following 4 month, patients will continue with rifampin and isoniazid (Jain et al., 
2008). The usage of multiple drugs is necessary to support the elimination of actively 
replicating bacilli.  
 
The continuation phase involves most patients with pulmonary or extrapulmonary TB. 
The anti-TB drugs in this phase consists of rifampicin and isoniazid which 
administered daily in 4 to 7 month duration. In most patients, this phase usually last 
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for 4 month except for the patient who did not take pyrazinamide in their initial phase 
of treatment, patients with cavitary pulmonary disease caused by drug-susceptible TB, 
patients whose sputum culture remains positive at the end of intensive treatment and 
patients whose receiving isoniazid with rifampicin once in a week but the culture 
remains positive for M. tuberculosis after the intensive treatment (Inge and Wilson., 
2008).  In the case of TB patient co-infected with HIV, taking anti-TB drugs may 
reduce the effectiveness of antiviral drugs. In such cases, the patients may stop taking 
antiretroviral therapy while they complete the short course of TB regimen which 
includes rifampin. Otherwise, rifampin may be replaced with other anti-TB drugs 
which is less likely to interfere AIDS medications (Bhowmik et al., 2009).  
 
The goal of TB treatment is to minimize the transmission of the bacteria and to cure 
the individual infected with the disease. Furthermore, an effective treatment depends 
on the several factors such as the susceptibility of the bacterial strain to anti-TB drugs, 
the adherence of patients to the TB regimen and also the duration of therapy. In many 
cases, patients always fail to finish the course of therapy when they start to feel better 
after some time of the therapy. However, by stopping the treatment too soon may result 
in resistance of the bacteria to the drugs and lead to the development of MDR-TB 
(Tsara et al., 2009). The resistant strain is more dangerous, difficult to treat and may 
become fatal and contributed major problem in the TB management. Thus, The World 
Health Organization (WHO) has developed a program known directly observed 
therapy short course (DOTS) to help patients in managing and monitor their course of 
therapy. In this program, a nurse or health care professional will monitor all patients 
taking the doses of the drugs required in the course of therapy, rather than relying on 
patients to take the medicine by their own (Chan and Iseman, 2002; Bhowmik et al., 
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2009). DOTS has been introduced in Malaysia in late 1990s and became part of 
national TB program. DOTS has improved the cure rate in many countries in but not 
in Malaysia (Ronaidi et al., 2011). The cure rate had declined in 2005 and 2006 from 
70% to 48%, respectively although overall the cure rate was 100% from 2000 to 2007 
(Ronaidi et al., 2011). 
 
Currently, the only available vaccine that has been used widely throughout the world 
since 1921 is Mycobacterium bovis, bacilli Calmette- Gue´rin (BCG) (Colditz et al., 
1994; Reyn and Vuola, 2002; Bowmik et al, 2009). Although it has been administered 
in order to prevent the disease, the BCG vaccine has been shown to be only effective 
in preventing childhood TB. Due to this reason, BCG vaccination has been applied to 
the newborn to confer protection against the serious forms of childhood TB and the 
efficacy of the vaccine wanes over the period of 10 to 15 years (Dam and Hitz, 1980; 
Rodrigues et al., 1991; and Brandt et al, 2002).  Furthermore, the efficacy of BCG 
vaccine is inconsistent in adults and caused a false positive result in tuberculin skin 
test (TST). Although there are several vaccine candidates which has been 
demonstrated in animal models which shows an equal to or superior to the BCG 
vaccine, the trial on human as the subjects is still underway. Due to this factor, the 
development of an improved and effective vaccine will require a prolonged period of 
time. In related development, 16 different vaccine candidates are currently under in 
clinical-phase trials (Achkar et al., 2015). 
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1.10 Laboratory diagnosis 
 
1.10.1 Direct microscopic examination of clinical specimens and routine culture 
isolation 
 
The most widely applied routine laboratory diagnosis of TB comprised of microscopic 
examination of the respiratory samples for acid-fast bacilli using Ziehl-Neelsen (ZN) 
staining method and culture isolation of the organism (Shingadia and Novelli, 2003; 
Garg et al., 2003; Palomino, 2005; Kashyap et al., 2007; Emovon, 2009). The presence 
of acid-fast bacilli (AFB) in pink colour indicate the presence of tubercle bacilli. The 
advantages of this method are inexpensive and rapid as the result should be available 
within 24 hours after specimen collection. Hence, it has been widely used in resource-
poor countries (Brodie and Schluger, 2005). In addition, the number of infecting 
bacilli can be estimated and thus, the extent of an individual infectiousness of the 
disease can be assessed. However, different species of mycobacteria can appear 
similar on the AFB staining and will lead to the low sensitivity and specificity result. 
Thus, AFB smear alone without culture cannot distinguish between M. tuberculosis 
and NTM species (Eichbaum and Rubin, 2002). Another constraint, it required greater 
than 10⁴ bacilli per ml of sputum. In the case of TB among children and HIV patients, 
an inadequate amount of sputum will lead to the greater failure rate which later on 
could be mistreated the disease (Ghadiri et al., 2008). 
 
To date, in laboratory diagnosis, culture technique remains as a gold standard which 
definitive diagnosis of TB and other mycobacterial disease relies. The bacteria can be 
isolated from various clinical samples such as sputum, body fluid, abscess and wound. 
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However, it is time consuming and due to the slow growth on the Lowenstein-Jensen 
(LJ) medium, it required a mean of the incubation period for at least 2-4 weeks to yield 
results (Kidenya et al., 2013). This will lead to the delay of the result and treatment of 
the patients. In-house medium such as Kirchner or various Middlebrook formulations 
also has been widely used but lack of standardization while semi-automated culture 
such as BACTEC system is quite expensive (Heifets et al., 2000). In addition, it needs 
the disposal of radioactive material and cannot be used for confirmation of the colony 
morphology (Emovon, 2009).  
 
1.10.2 Tuberculin skin test 
 
Tuberculin skin test (TST) is a common and oldest diagnostic test in the history of TB 
diagnosis.  In this test, purified protein derivative (PPD) is injected intradermally and 
the reaction to the injection is read after 48-72 hours by measuring the diameter of 
induration in the unit of millimeter (Emovon, 2009; Tsara et al., 2009; Lange and 
Mori, 2010). According to WHO guideline, positive TST is regarded as positive when 
a person showing induration of >10mm without prior vaccination previously and 
>15mm for those who had vaccinated with BCG vaccine (Shingadia, 2012). 
Traditionally, this test was used to diagnose LTBI. However, the limitation of TST is 
low specificity because it contains a mixture of antigens that may cross react with 
many Mycobacterium species. The false positive result may also occur when a person 
had exposed to the infection by NTM and when a person had a history of BCG 
vaccination. In addition, the false negative result may occur as the result of severe TB 
and immunocompromised patients (Kashyap et al., 2007; Tsara et al., 2009). 
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However, this does not rule out the TB. Further testing is needed for the confirmation 
of the disease. 
 
1.10.3 Radiology 
 
In conjunction of TST, screening of chest radiography is often used when the TST 
result may be unreliable. The purpose of chest radiography is to screen if a person 
develops an active TB (Leung, 1999). In the case of an individual infected with both 
active TB and HIV, the chest X-ray may show a ‘normal’ appearance, thus chest X-
ray may not be definitive (Burrill et al., 2007). In addition, the interpretations are very 
subjective which required an expertise to do the interpretation and result can be non-
specific. 
 
Computing tomography (CT) imaging is more sensitive than conventional chest X-ray 
and  may be helpful in describing and identifying pulmonary TB such as 
endobronchiol disease, early cavitation and bronchiectasis which follow by pulmonary 
TB  where chest X-rays are normal or unreliable (Shingadia and Novelli, 2003; Lange 
and Mori, 2010). Furthermore, CT imaging may also helpful in investigating other 
form of TB such as TB meningitis or tuberculoma (Shingadia, 2012). 
 
1.10.4 Immunodiagnosis of tuberculosis 
 
Generally, the immunological based assay is preferred over the bacteriological method 
in the diagnosis of TB because it does not depend on the detection of bacteria (Abebe 
et al., 2007). In immunology of TB, it comprises of two categories of method which 
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is method that measure cellular immune response  to detect latent TB infection (LTBI) 
and method that measure antibodies level response to specific antigens in diagnosing 
active TB (Davies and  Pai, 2008).  
 
A test that measures cellular immune response is known as interferon-gamma release 
assay (IGRA) which emerges as an alternative to TST. The LTBI are detected by 
measuring interferon-gamma (IFN-γ) released from the T-cells after the stimulation 
with TB specific antigens. However, IGRAs like the TST are incapable in 
discriminating between active TB disease and LTBI cases (Janssens, 2007). Of all the 
issues above, it should be highlighted that IGRAs were designed to detect the infection 
of M. tuberculosis instead of active TB disease. 
 
On the other hand, a serology test method which is based on antibody-antigen 
detection measures the antibody level of an individual that response to the particular 
antigens. It is an alternative approach to support an early conclusion of the laboratory 
diagnosis of TB. In the past decades inefficient performance of a serological assay has 
resulted in extensive studies that lead to the better understanding of the humoral and 
cellular response of TB. There are still some important criteria need to be taken into 
account in choosing a diagnostic test such as sensitivity, specificity, positive predictive 
value, cost, labour intensiveness and the availability of the antigen required with 
acceptable cost. 
 
In this regard, there are a number of reviews on the serology of TB that demonstrating 
the low sensitivity and specificity of the test. Currently, there are many serological 
tests have been developed to diagnose TB disease but there are no commercially 
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available serodiagnostic tests for TB with acceptable sensitivity and specificity for 
routine laboratory use (Abebe et al., 2007). In order to overcome this constraint, 
researcher suggested that a combination of antigens in the assay may yield the desired 
level of sensitivity, without affecting specificity (Lyashchenko et al., 2000; Abebe et 
al., 2007; Steingart et al., 2009)  
 
In TB serology, many commercialized serological test kits are based on the detection 
IgG, IgM and IgA antibodies to the specific antigens of MTB. However, the studies 
showed that IgG antibody response is more promising in diagnosing an active TB in 
adults and children (Bhatia et al., 2003). However, the inconsistency elevation of all 
three antibody isotypes in active infection making it important to determine the ideal 
antibody isotypes for developing a reliable assay (Abebe et al., 2007). 
 
1.10.5 Molecular techniques for diagnosis and species differentiation 
 
In an attempt to overcome the limitations of conventional method in diagnosis of TB, 
several studies have been reported regarding the development of molecular method to 
detect the presence of M. tuberculosis in the clinical specimens. Nucleic acid 
amplification (NAA) technique is a molecular test which is based on the detection of 
highly specific fragments of nucleic acids, DNA or RNA of M. tuberculosis and 
followed by amplification of the target sequences that indicate the presence of the 
bacteria in the specimens (Brodie et al., 2005; Green et al., 2009; Drobniewski et al., 
2012). The application of NAA may contribute a valuable tool to complement the 
conventional approach to the diagnosis of TB (Laraque et al., 2009). The advantages 
of NAA are it is highly efficient and hold the great potential in early diagnosis of TB, 
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particularly in the case of the infection in the certain body part which the progress is 
very fast while the culture method is time consuming to yield result (Laraque et al., 
2009). NAA is also very sensitive as it may detect presence of one to two mycobacteria 
in the specimen. However, due to the highly sensitive even the smallest amount of 
contaminating DNA can be amplified and may lead to the misinterpretation of the 
result (Jain et al, 2008). In addition, it also may detect nonviable tubercle bacilli and 
NAA negative result must be interpreted carefully due to the presence of inhibitors of 
NAA in the samples that contribute to the false negative result (Paramasivan, 2006). 
Furthermore, NAA assay requires a specialized instrument, trained personnel, costly 
and it cannot be considered as a rapid test. This approach is still in the research phase 
and yet to be user-friendly. Thus, NAA assay is a compliment but not a substitute for 
culture method. 
 
1.11 Problem statements 
 
In TB diagnosis, clinical manifestation of TB is protean and as the result, diagnosis of 
TB often difficult (Zumla et al., 2013). The non-specific symptoms that occur in the 
patients may not be sufficient to be included as diagnostic criteria. Physical signs are 
not always present in the early stage of the disease while the absence of the signs does 
not rule out the disease. Furthermore, TB symptoms can mimic many different 
diseases especially other pulmonary disease and this remains a diagnostic dilemma 
(Hammen, 2015). Diagnostically, culture isolation remain as the gold standard for 
Mycobacterium species identification but often time consuming. As from treatment 
aspect, the emergence of MDR-TB which rapidly develop resistance to the first line 
drug and monotherapy treatment create another obstacle. On the other hand, the widely 
